Skip to Main Content

INFORMATION FOR

    Phase II

    Efficacy of Guselkumab in the treatment of Hailey Hailey disease: An open-label, proof of concept study

    Contact Information

    For more information about this study, including how to volunteer, contact Marianne Sparapani-Rusgrove

    Help Us Discover!

    You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

    • Last Updated
      03/24/2026
    • Study IRB
      #2000038224